Post-transfusion mortality among recipients of ABO-compatible but non-identical plasma

Impact of ABO-identical vs ABO-compatible nonidentical plasma transfusion in trauma patients.

HYPOTHESIS Exposure to ABO-compatible nonidentical plasma will result in worse outcomes than transfusion with ABO-identical plasma only. DESIGN Retrospective study. SETTING Level I trauma center. PATIENTS All patients requiring plasma (from 2000-2008) were identified. Propensity scores were used to match patients exposed to ABO-compatible plasma with those receiving exclusively ABO-identi...

Is ABO-Compatible but Non-Identical Intestinal Transplant Comparable to ABO-Identical Transplant? An Analysis of the UNOS Registry

Junchao Cai1*, Xin Qing2, Guosheng Wu3, Matthew Everly1, Elaine Cheng1,4, Paul Terasaki1 1Terasaki Foundation Laboratory, Los Angeles, CA, United States 2Department of Pathology, Harbor-UCLA Medical Center, Torrance, CA, United States 3Xijing Hospital of Digestive Diseases, the Fourth Military Medical University, Xi’an, China 4Department of Surgery, UCLA Medical School, Los Angeles, CA, United ...

Efficacy and Adverse Events of Platelet Transfusion Product-Specific Differences.

SUMMARY: TWO PREPARATIONS ARE AVAILABLE FOR PLATELET TRANSFUSION: single-donor apheresis platelet concentrates (APC) and pooled platelet concentrates (PPC) prepared from 4-6 whole blood units. Clear advantages of APC over PPC are a markedly reduced donor exposure of recipients, and easier logistics when attempting a complete supply with ABO-identical and Rh-compatible platelet concentrates. Reg...

Red blood cell non-ABO-identical transfusions are harmful: really?

Cancer risk among 21st century blood transfusion recipients

Background Some carcinogenic viruses are known to be transmissible by blood transfusion. Intensive viral screening of transfused blood now exists in most countries. In the UK, high-sensitivity nucleic acid amplification tests for hepatitis C virus were introduced in 1999 and it was thought that this would reduce, and possibly eliminate, transfusion-related liver cancer. We aimed to investigate ...